Study finds erectile dysfunction drugs linked to lower Alzheimer’s risk

Researchers evaluated the effect of phosphodiesterase-5 inhibitor (PDE5I) initiation compared to non-use and Alzheimer’s disease development risk among males suffering from erectile dysfunction.

University of Birmingham and Acticor Biotech announce MHRA approval of LIBERATE clinical study

September 7th, 2023, the University of Birmingham and Acticor Biotech announce the full regulatory approval of LIBERATE clinical study.

September 9, 2023

Bicara raises $165m to advance cancer therapy – Pharmaceutical Technology

Share this article Bicara’s BCA101 showed an 89% disease control rate in patients with head and neck squamous cell carcinoma (HNSCC) in interim data from

December 14, 2023

How does the nasal cavity’s immune system combat SARS-CoV-2?

Researchers discovered that CD4+ and CD8+ T cells play a crucial role in clearing COVID-19 infection in the nasal cavity but have limited impact on

January 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.